Skip to content
Search

Latest Stories

RPS hires communications agency Luther Pendragon to review member participation

The Royal Pharmaceutical Society (RPS) has appointed communications agency to lead a review into how it can develop and strengthen member participation.

"We've appointed communications consultancy Luther Pendragon to carry out an independent review of the participation of members and of our communications concerning decisions we take on behalf of the profession through our Governance boards," the Society said in a statement on Tuesday (May 10).


It added that review would examine how RPS members, elected members and stakeholders can feel engaged, informed and empowered to influence decisions about RPS policy and understand why decisions around organizational policy have been taken on their behalf by elected representatives.

It will also ensure RPS decision-making processes are open and transparent with an emphasis on evidence-based decision making, and recommend ways elected members are enabled to be publicly accountable for decisions taken by the organization at Board and Assembly level.

Luther Pendragon will conduct in-depth reviews -- seeking views of members and elected members as well as individuals and organizations outside the profession, about how participation can be developed and strengthened.

The agency will use a combination of focus groups, online surveys and one-to-one interviews to build a detailed understanding of views, on which to base a series of recommendations for the RPS.

Luther will then develop a corporate communications strategy which will include action plans for each of the RPS’s target audiences in order to enable greater participation.

RPS committed to making changes

RPS president Professor Claire Anderson said: “Now we have appointed Luther Pendragon and have a robust review process in place we can build a new approach to participation and communications with our members, elected members and stakeholders.

“I look forward to hearing your views and building them into the independent review, which we will publish when it is complete. I am committed to making changes based on its recommendations.”

Part of the Crown Commercial Service, Luther Pendragon has worked with various pharmacy organizations, NHS England, and the Department of Health & Social Care.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less